Osaic Holdings’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-199
| Closed | -$8.55K | – | 7673 |
|
|
2024
Q2 | $8.55K | Buy |
+199
| New | +$8.45K | ﹤0.01% | 5883 |
|
|
2024
Q1 | – | Sell |
-1,283
| Closed | -$53.6K | – | 7459 |
|
|
2023
Q4 | $53.6K | Buy |
1,283
+920
| +253% | +$33.9K | ﹤0.01% | 4864 |
|
|
2023
Q3 | $13.7K | Buy |
363
+264
| +267% | +$9.91K | ﹤0.01% | 5754 |
|
|
2023
Q2 | $3.75K | Hold |
99
| – | – | ﹤0.01% | 6435 |
|
|
2023
Q1 | $2.41K | Buy |
99
+11
| +13% | +$321 | ﹤0.01% | 6638 |
|
|
2022
Q4 | $3K | Buy |
88
+16
| +22% | +$475 | ﹤0.01% | 6560 |
|
|
2022
Q3 | $2K | Hold |
72
| – | – | ﹤0.01% | 6874 |
|
|
2022
Q2 | $3K | Sell |
72
-17
| -19% | -$648 | ﹤0.01% | 6793 |
|
|
2022
Q1 | $4K | Buy |
89
+45
| +102% | +$2.1K | ﹤0.01% | 6661 |
|
|
2021
Q4 | $2K | Sell |
44
-116
| -73% | -$6.5K | ﹤0.01% | 7079 |
|
|
2021
Q3 | $10K | Buy |
160
+24
| +18% | +$1.66K | ﹤0.01% | 6222 |
|
|
2021
Q2 | $10K | Buy |
136
+5
| +4% | +$367 | ﹤0.01% | 6088 |
|
|
2021
Q1 | $10K | Buy |
131
+96
| +274% | +$7.29K | ﹤0.01% | 5880 |
|
|
2020
Q4 | $3K | Sell |
35
-196
| -85% | -$12.6K | ﹤0.01% | 5999 |
|
|
2020
Q3 | $13K | Buy |
231
+10
| +5% | +$622 | ﹤0.01% | 5151 |
|
|
2020
Q2 | $15K | Hold |
221
| – | – | ﹤0.01% | 4983 |
|
|
2020
Q1 | $14K | Buy |
+221
| New | +$16.4K | ﹤0.01% | 4845 |
|
Other funds holding TARO
Osaic Holdings's TARO Position: Q3 2024 in Review
Osaic Holdings sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2024, closing a stake of 199 shares — an estimated $8.55K sold.
Osaic Holdings first reported a position in TARO in Q1 2020 and held it in 17 quarters. The position peaked at $53.6K in Q4 2023. 6 funds tracked by Wall St. Rank hold TARO as of Q3 2024.
- Osaic Holdings reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2024 after selling out during the quarter.
- Osaic Holdings sold 199 Taro Pharmaceutical Industries Ltd. shares in Q3 2024, an estimated $8.55K.
- Osaic Holdings first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2020 and held it in 17 quarters.
- Osaic Holdings's Taro Pharmaceutical Industries Ltd. position peaked at $53.6K in Q4 2023.
- 6 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2024.
Based on Osaic Holdings's 13F filing for Q3 2024, filed 13 Nov 2024.